WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Fares Ali
PeerJ Reviewer
850 Points

Contributions by role

Reviewer 15
Editor 835

Contributions by subject area

Biochemistry
Cell Biology
Molecular Biology
Histology
Biotechnology
Diabetes and Endocrinology
Nutrition
Metabolic Sciences
Obesity
Toxicology
Emergency and Critical Care
Pathology
Oncology
Pharmacology
Plant Science
Evidence Based Medicine
Drugs and Devices
Epidemiology
Immunology
Infectious Diseases
Bioinformatics
Computational Biology
Clinical Trials
Data Science
Neuroscience

Fares E.M Ali

PeerJ Reviewer

Summary

Dr. Fares E.M Ali is an Assistant Professor within the Pharmacology and Toxicology Department, Al-Azhar University, Assiut, Egypt. Fares primary research interests include Hepatology, Gastroenterology, Clinical Pharmacology, Toxicology, and Nephrology. Their current projects are 'Cholestatic liver injury: new vision, renal fibrosis management, and overcoming cancer chemotherapy adverse effects.

Cell Biology Food Science & Technology Molecular Biology Pharmacology Toxicology

Past or current institution affiliations

Al Azhar University

Work details

Assistant professor

Al Azhar University
Pharmacology and Toxicology
I do research in Hepatology, Gastroenterology, Clinical Pharmacology, Toxicology, and Nephrology. The current projects are 'Cholestatic liver injury: new vision, renal fibrosis management, and overcome cancer chemotherapy adverse effect.

Websites

  • Google Scholar
  • PubMed Search

PeerJ Contributions

  • Edited 4

Academic Editor on

December 12, 2023
New insights into the role of GSK-3β in the brain: from neurodegenerative disease to tumorigenesis
Shenjin Lai, Peng Wang, Jingru Gong, Shuaishuai Zhang
https://doi.org/10.7717/peerj.16635 PubMed 38107562
November 15, 2023
Pharmacokinetic and pharmacodynamic herb-drug interactions—part I. Herbal medicines of the central nervous system
Szilvia Czigle, Milan Nagy, Přemysl Mladěnka, Jaroslav Tóth
https://doi.org/10.7717/peerj.16149 PubMed 38025741
September 29, 2023
Pathway2Targets: an open-source pathway-based approach to repurpose therapeutic drugs and prioritize human targets
Mauri Dobbs Spendlove, Trenton M. Gibson, Shaney McCain, Benjamin C. Stone, Tristan Gill, Brett E. Pickett
https://doi.org/10.7717/peerj.16088 PubMed 37790614
May 9, 2023
Epithelial to mesenchymal transition in mammary gland tissue fibrosis and insights into drug therapeutics
Mudasir Ahmad Syed, Basharat Bhat, Abiza Wali, Afnan Saleem, Lateef Ahmad Dar, Mudasir Bashir Gugjoo, Shakil Bhat, Sahar Saleem Bhat
https://doi.org/10.7717/peerj.15207 PubMed 37187521